At PMI U.S., we are building a modern nicotine business—focused on helping make a future without cigarettes a reality in America. As the U.S. businesses of Philip Morris International, we are investing in new products, science, and capabilities to provide the approximately 25 million legal‑age adults who still smoke with better alternatives.
Our approach is rooted in innovation, responsible marketing, and a growing U.S. footprint that spans manufacturing, technology, and commercial operations across the country.
That creates real opportunity. You’ll have the space to take ownership, develop new ideas, and contribute to work that is shaping our business and the category. We’re looking for people who are curious, collaborative, and motivated by progress—because the scale of what we’re building creates room to grow in different directions.
As part of PMI’s Illicit Trade Prevention (ITP) team, the Manager ITP Forensics US serves as the subject matter expert for tobacco and smoke-free product (SFP) forensics, including oral nicotine products. This role supports intellectual property protection efforts through product authentication, forensic analysis, investigations, intelligence generation, litigation support, and collaboration with law enforcement and industry partners. The position plays a critical role in protecting PMI’s brands, products, consumers, and supply chain from illicit trade activities.
Your Day-to-Day
Who We’re Looking For:
What’s Nice to Have:
Annual Base Salary Range: $120,000 - $150,000
PMI is an Equal Opportunity Employer.
PMI is headquartered in Stamford, Conn., and its U.S. affiliates have more than 3,000 employees.
PMI has been an entirely separate company from Altria and Philip Morris USA since 2008. PMI’s affiliates first entered the U.S. market following the company’s acquisition of Swedish Match in late 2022. Philip Morris International and its U.S. affiliates are working to deliver a smoke-free future. Since 2008, PMI has invested $12.5 billion globally to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke with the goal of transitioning legal-age consumers who smoke to better alternatives. In 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the IQOS and ZYN brands. The U.S. Food and Drug Administration has authorized versions of PMI’s IQOS electronically heated tobacco devices and Swedish Match’s General snus as Modified Risk Tobacco Products and renewal applications for these products are presently pending before the FDA. For more information, please visit www.pmi.com/us and www.pmiscience.com.
#PMIUS
#LI-JN1